As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...

A simple digital health tool developed by Australian researchers could soon help predict the age of onset for early Alzheimer ...

Revised guidelines for amyloid and tau positron emission tomography for Alzheimer’s disease and dementia state these tests ...

There is a potential link between Alzheimer's disease and the herpes simplex virus-1 (HSV-1), which is a common cause for ...

Neurologists hope this tongue-in-cheek study will spark serious conversations about AI's limitations and the benefits of a human touch in medicine.

For decades, scientists have been trying to develop therapeutics for people living with Alzheimer’s disease, a progressive ...

Study reveals surprising connection between common childhood virus CMV and Alzheimer's disease, offering new insights into ...

Medics have revealed how long a person can expect to live after being diagnosed with dementia. Survival rates range between two and nine years on average, the study suggests. Various factors appear to ...

A University of California, Irvine-led research team has discovered intricate molecular mechanisms driving the RNA processing ...

POTOMAC, MD / ACCESSWIRE / January 8, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC Pharma" or the "Company") announced today that its ongoing Phase 2 trial for agitation in Alzheimer's disease ...

All 16 of Indiana’s designated senior care organizations — known as Area Agencies on Aging — are now required to have a ...